INVIMA Colombia Medical Device Postmarket Compliance
Last reviewed:
Medical device postmarket compliance in Colombia includes renewals, modifications, and vigilance requirements.
Medical device and IVD registration renewals in Colombia
Your INVIMA registration must be renewed to continue selling in Colombia. The renewal application should be submitted at least three (3) months before your device’s registration expires. Medical device registrations are valid for 10 years. For IVDs, renewal applications should be initiated six (6) months prior to registration expiration. Category I and II IVDs are valid for ten years; Category III IVD registrations are valid for five (5) years.
The renewal process will be similar to your initial registration process and will require an up-to-date product dossier. If your Class I or IIa device received automatic approval, you can obtain approval for your renewal application in a few working days following your submission. INVIMA performs official reviews for higher risk device renewals, which can take at least 90 days.
Medical device modification requirements in Colombia
Administrative modifications to your device can be submitted as change notifications, such as a change of importer or health license owner, as well as some product-specification changes, such as a change of composition, labeling, warnings, etc. Modifications that affect the security or effectiveness of the product, or changes to its design and chemical composition require a new registration. For IVDs, changes to basic composition, reformulations, or major changes to the initial approval characteristics require a new registration.
Documentation requirements for a change notification will depend on the type of modification being submitted. INVIMA approves change requests within a few working days as long as the documentation is complete. However, you may receive a request for information following your modification approval as INVIMA reviews your modification documentation in more detail. You have 90 days to fulfill a request for information.
Medical device Post-market Surveillance and Vigilance in Colombia
Medical device companies must establish a pharmacovigilance system to monitor their device’s performance and collect information about adverse events. Manufacturers and importers share vigilance obligations and must each submit a quarterly PMS report, called a Period Report, even in the absence of a reportable event. Serious adverse events must be reported to INVIMA within 72 hours of knowledge of the event; non-serious adverse events must be reported within eight (8) business days.
Regulatory Update · Nov 11, 2025Colombia INVIMA 2026 Guidance Clarifies UDI-DI Requirements for Class IIa Medical DevicesRegulatory Update · Sep 10, 2024Weekly Regulatory News: Sep 3-9, 2024Research Report · Jul 27, 2026IVD Global Market Access 2026Blog Article · May 29, 2026Turn FDA & EU Approvals Into Global Market AccessBlog Article · Sep 23, 2025Medical Device Registration Costs and Timelines for Brazil, Mexico, and ColombiaVideo · Jul 21, 2025How to Register a Medical Device with INVIMA in ColombiaRegulatory Update · Jul 21, 2026ANVISA Named WHO Transitional Listed AuthorityRegulatory Update · Jul 16, 2026ANVISA Brazil-Chile Regulatory Cooperation 2026Case Study · Jul 22, 2026Single-Use Endoscope Registration in Brazil: Time & CostResearch Report · Jul 20, 2026Orthopedic Implants: The 2026 Global Market-Access MapFull INVIMA Support for a Simple Annual Fee
Pure Global replaces fragmented regulatory consulting fees with a single annual cost that covers registration, representation, and ongoing compliance. From faster, AI-enabled dossier preparation to post-market surveillance, everything required to keep your device compliant in Colombia is included. No hourly billing or unexpected invoices.
Frequently asked questions
A serious adverse event is an event concerning your device that caused or could have led to death or serious deterioration in the health of the user or patient. A non-serious adverse event is an event concerning your device that could not have led to death or serious deterioration in the health of the user.
Evaluate any foreign event for relevance to devices supplied in Colombia, including whether it changes the benefit-risk profile or triggers a field action. Events and safety actions meeting Colombian reporting criteria should be escalated through the local holder within the applicable timelines; location alone is not the only test.
Manufacturers and importers must implement field safety corrective actions (FSCAs) once they become aware of an adverse event or incident and document the response in the Periodic Reports provided to INVIMA. If the event is serious enough that a recall is necessary, you must inform INVIMA that your device is being removed from the Colombian market, including specific batch numbers, the reason for the withdrawal, timelines for complete withdrawal, etc.
Single Process,
Multiple Markets
When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.
Let's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us